Replies to post #9074 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Insider Transactions During Past 18 Months

[Includes transactions through 3/12/08. Please
see #msg-27617453 for current insider holdings.]


PURCHASES

Geoffrey Cox, CEO
13-Dec-2007 10,765 shares @$0.88-0.90
13-Aug-2007 14,200 shares @$1.02-1.03
14-Mar-2007 24,000 shares @$0.99-1.01
08-Nov-2006 14,300 shares @$1.05-1.07
===
Total (4 purchases): 63,265 shares @$0.88-1.07

Jack Green, CFO
14-Dec-2007 1,500 shares @$0.89

Harry Meade, SVP Research
14-Dec-2007 10,000 shares @$0.90

Greg Liposky, SVP Oprtns
17-Dec-2007 1,100 shares @$0.87

Daniel Woloshen, Gen. Counsel
17-Dec-2007 1,200 shares @$0.89

James Geraghty, Director
14-Dec-2007 10,000 shares @$0.87

Mary Ann Gray, Director
17-Dec-2007 10,000 shares @$0.88


SALES

Daniel Woloshen, Gen. Counsel
12-Mar-2008 17,000 shares @$0.57
22-Dec-2006 7,500 shares @$1.10

Greg Liposky, SVP Oprtns
12-Mar-2008 8,000 shares @$0.56-0.57


SEC links:
http://www.sec.gov/Archives/edgar/data/904973/000090866207000400/xslF345X02/edgar.xml
http://www.sec.gov/Archives/edgar/data/904973/000090866207000291/xslF345X02/edgar.xml
http://www.sec.gov/Archives/edgar/data/904973/000090866207000131/xslF345X02/edgar.xml
http://www.sec.gov/Archives/edgar/data/904973/000118095506000107/xslF345X02/edgar.xml
http://www.sec.gov/Archives/edgar/data/904973/000090866207000406/xslF345X02/edgar.xml
http://www.sec.gov/Archives/edgar/data/904973/000090866207000407/xslF345X02/edgar.xml
http://www.sec.gov/Archives/edgar/data/904973/000090866207000409/xslF345X02/edgar.xml
http://www.sec.gov/Archives/edgar/data/904973/000090866207000411/xslF345X02/edgar.xml
http://www.sec.gov/Archives/edgar/data/904973/000090866207000435/xslF345X02/edgar.xml
http://www.sec.gov/Archives/edgar/data/904973/000090866207000413/xslF345X02/edgar.xml
http://www.sec.gov/Archives/edgar/data/904973/000090866208000109/xslF345X02/edgar.xml
http://www.sec.gov/Archives/edgar/data/904973/000090866206000415/xslF345X02/edgar.xml
http://www.sec.gov/Archives/edgar/data/904973/000090866208000110/xslF345X02/edgar.xml

[DewDiligence]

Current Insider Shareholdings and Options

[Includes transactions through 3/14/08. Other than the options
granted with an exercise price of 0.63 on 3/7/08 (#msg-27509339),
all options have an exercise price greater than 1.00.]

 
 	 
 Executive Officers  
 Geoffrey Cox, CEO          452K shares   991K options 
 John Green, CFO            116K shares   414K options 
 Harry Meade, SVP Research  157K shares   383K options 
 Greg Liposky, SVP Oprtns    83K shares   371K options 
 Dan Woloshen, Gen. Counsel 100K shares   287K options 
 Dick Scotland, SVP Regltry  98K shares  *267K options 
 -- 
 Six executive officers   1,006K shares 2,713K options

 
 Non-executive directors  
 Robert Baldridge             5K shares    75K options 
 Kenneth Bauer                 0 shares    38K options 
 Christian Béchon            18K shares    15k options 
 Francis Bullock             11K shares    74K options 
 James Geraghty              88K shares   163K options 
 Michael Landine               0 shares    38K options 
 Pamela McNamara              9K shares    53K options 
 Marvin Miller                8K shares    53K options 
 Alan Tuck                   14K shares    51K options 
 Mary Ann Gray               11K shares    15K options 
 -- 
 Ten non-executive directrs 164K shares   575K options

 
 All officers/directors   1,170K shares 3,288K options

*Because Scotland’s detailed options holdings are not shown in GTC’s DEF14a filings, his number of options shown above is an estimate.